Australia's most trusted
source of pharma news
Thursday, 11 September 2025
Posted 11 September 2025 AM
Lundbeck has announced it will bow out of 27 markets and lay off 602 staff members globally as it transitions to a new commercial partnership model, but the Australian team has been spared.
The company will retain in-country commercial operations in Australian and 21 other markets but its decision to exit 27 countries means its presence on the ground globally will be more than halved.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.